Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS
· Delayed Price · Currency is USD
0.1100
+0.0480 (77.42%)
May 7, 2025, 4:00 PM EDT
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $172.80 thousand as of May 9, 2025. Its market cap has decreased by -92.54% in one year.
Market Cap
172.80K
Enterprise Value
13.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 172.80K, a decrease of -99.80%. That is a compound annual growth rate of -74.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 172.80K | -87.58% |
| Dec 31, 2024 | 1.39M | 27.08% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | 62.11M | -26.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.67B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 761.84M |
| Tian'an Technology Group | 546.22M |
| Glass House Brands | 511.43M |
| CytoDyn | 482.88M |
| Elite Pharmaceuticals | 446.59M |
| Northwest Biotherapeutics | 390.49M |